US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Shepherd Ave Capital Acquisition Corporation (SPHAU)
Shepherd Ave Capital Acquisition Corporation (SPHAU) ニュース

Shepherd Ave Capital Acquisition Corporation (SPHAU)

10.24

0.00

(0.00%)

終了 6月10日 5:00AM

0.00

0.00

(0.00%)

取引時間後: -

個人投資家向けのプロ仕様のツール。

プレミアム

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Form 8-K - Current report

Form 8-K - Current report

Shepherd Ave Capital Acquisition Corporation Announces Corporate Name Change

Wilmington, DE, March 11, 2025 (GLOBE NEWSWIRE) -- Shepherd Ave Capital Acquisition Corporation (Nasdaq: SPHA) (“SPHA”) announced that...

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Form 8-K - Current report

Shepherd Ave Capital Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on January 27, 2025

Wilmington, DE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Shepherd Ave Capital Acquisition Corporation (the “Company”) (Nasdaq: SPHAU), a blank check...

Shepherd Ave Capital Acquisition Corp Announces Closing of Initial Public Offering

Wilmington, DE, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Shepherd Ave Capital Acquisition Corporation (NASDAQ: SPHAU) (“SPHA” or the “Company”...

Shepherd Ave Capital Acquisition Corporation Announces the Pricing of its $75 Million Initial Public Offering

Wilmington, DE, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Shepherd Ave Capital Acquisition Corporation (NASDAQ: SPHAU) (“SPHA” or the “Company”...

biosectinvestor

biosectinvestor 5分前

That sidesteps the point.

I am not defending every theory posted by every investor about the MHRA timeline. I am addressing your categorical argument: no tissue-agnostic biomarker, therefore no tissue-agnostic or platform pathway.

That argument still fails.

bluebird50

bluebird50 6分前

I think the winner here is a Deutche bank London transfer to California investors…
Big win maybe or a big wind down???
I’m sure the transaction even 10 cents on the dollar is 100 million plus… how long they want to sit on that investment?? Back in March.
I seen on the filing

jxyzobrien

jxyzobrien 6分前

in the morning trade brigade does
market take so i do not need this guy

Cheef Zed

Cheef Zed 8分前

Not surprised to see this dip after no one buying those 03s ! Waiting for some juicy updates hopefully 🤞

Just give me $1.50

Just give me $1.50 8分前

Keep your eyes peeled for the CC press release either tomorrow morning or Thursday morning.

June 15: 10-K
June 16: Mikah conference call

Thanks.

12yearplan

12yearplan 9分前

Good to go https://eservices.bcsc.bc.ca/eservices/docview/temp/BCSC_ReportingIssuers.pdf?t=1591900504955

biosectinvestor

biosectinvestor 11分前

You are not identifying a regulatory impossibility; you are identifying that DCVax does not fit a pathway FDA created for a different new class of drugs. That is not a rebuttal to the platform thesis. It is the class error.

----

So , no, this is not about verbiage. It i

haras

I guess it is fair to say : Kiss it good bye. 4 years in the waiting for nothing what a shame…

Duke Knockem

Duke Knockem 14分前

alright well go on Twitter and make a judge Judy of yourself man there only OTC retards on here and that includes myself

floblu14

floblu14 16分前

Addendum - from AI
Hearing Date: The UPC hearing is set for September 29, 2026, with a decision anticipated from the court within weeks following the hearing.

Mistervane

Mistervane 16分前

Not an obituary. Still speculation. “I’m hearing…” is not factual information.

Fangster

Fangster 17分前

Excellent find, Yoda! Great potential connection direct to the president.

satter

satter 17分前

I am not sure how the silver mine deal proceeds or others.

Since Hiru never posted a bond the plaintiff could have gone after assets at any time. I was surprised there was no prior activity. It appears they were either waiting for the appeal to conclude or doing investigative work.

ErnieBilco

ErnieBilco 18分前

Scinai Immunotherapeutics Ltd.
Jerusalem BioPark, 2nd Floor
Hadassah Ein Kerem Campus
Jerusalem
Israel

www.scinai.com

Cheef Zed

Cheef Zed 18分前

Interesting action lately … need some updates from company !!

ErnieBilco

ErnieBilco 19分前

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.

peafunke

peafunke 19分前

Good… I’ll keep buying.

Duke Knockem

Duke Knockem 20分前

https://x.com/i/status/2063989669667180674

Duke Knockem

Duke Knockem 20分前

https://x.com/i/status/2063989669667180674

17yearsnomoney

17yearsnomoney 20分前

I try to post on the RKT board however if you dare to call out the liars and misinformation that’s been posted for 17 years you end up here.

Crapola2theleft

Crapola2theleft 20分前

Sure sounds like projection !

JTORENCE

JTORENCE 20分前

brooktrail1933 The U.K. is not a big fan of the U.S. Add to that there are more than 5 million Muslims living in the U.K. Could one guess that at least 25% are anti American? Of those 25%, how many does the MHRA employ?
NWBO is a US company. Doesn't take much of an imagination to see th

biosectinvestor

biosectinvestor 22分前

I agree 100% Chiugray. They can whistleblow on their peers and who they are working with and way many, many times what they are now, likely a fortune, IMHO. Have a wonderful day!

floblu14

floblu14 22分前

There is an upcoming public oral hearing scheduled in Enanta Pharmaceuticals' European patent infringement case against Pfizer over the COVID-19 antiviral drug Paxlovid.

The Unified Patent Court (UPC) of the European Union has scheduled the hearing for September 29, 2026.Case Details:

mascale

mascale 25分前

Satter claim that USA has no courts(?): not literacy.

Shepherd Ave Capital Acq...

Airport City (PK)

Vanguard EUR Corporate B...

WisdomTree Issuer ICAV

Ci Global Smallmid Cap E...

Invesco S&P Internationa...

Ci Global Income & Growt...

RSE Collection (GM)

RSE Collection (GM)

Etfs Silver Micro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。